Attend the FierceBiotech Executive Breakfast at BIO 2019
Join us on June 5th for our panel discussion on real-world evidence. Reserve your seat today.
The FDA has cleared the first medical device for treating ADHD: an at-home nerve stimulation system designed for children ages 7 to 12.
Quest Diagnostics has launched three new test kits for STDs that consumers can order online, within the privacy of their own home.
Digital imaging analysis provider Aidoc has raised $27 million to help build out its go-to-market team, after processing its one-millionth CT scan.
Abbott Laboratories posted a 2% increase in sales for its first quarter this year, topping $7.5 billion worldwide and ahead of expectations.
IBM is ending sales of its Watson programs aimed at drug discovery and development over poor financial returns, according to a report from Stat.
Bardy Diagnostics, developers of a remote cardiac monitoring chest patch, raised $35.5 million to help fund its platform and expand its sales force.
The two remaining U.S. manufacturers of transvaginal surgical mesh have been ordered by the FDA to halt the sale and distribution of those products.
Thermo Fisher Scientific is bringing high-tech upgrades to its real-time PCR instruments it says are designed to improve the user experience.
Researchers in Israel have printed a three-dimensional human heart using bioinks developed from a patient’s own cells.
The companion diagnostic test was launched at a handful of initial laboratories through Qiagen’s Day-One Lab Readiness program.
